testosterone

In $500M deal, Bayer offloads testosterone deficiency drug Nebido to Grünenthal
Fierce Pharma
Thu, 07/14/22 - 07:58 pm
Bayer
testosterone
hypogonadism
Grunenthal
Clarus picks up FDA OK for oral testosterone drug
BioPharma Dive
Sat, 03/30/19 - 12:05 am
Clarus Therapeutics
testosterone
FDA
Jatenzo
Bucking the trend, Antares gains FDA OK for testosterone rejection on second try
Endpoints
Tue, 10/2/18 - 10:05 am
Antares Pharma
XYOSTED
testosterone
FDA
AbbVie wins reversal of $140 million verdict in case over AndroGel risks
Reuters
Fri, 07/6/18 - 11:15 am
AbbVie
Androgel
testosterone
After setting aside $200M, Endo settles 1,300 testosterone liability lawsuits
Fierce Pharma
Tue, 06/12/18 - 11:26 am
Endo International
testosterone
U.S. jury orders AbbVie to pay $3 million in AndroGel retrial
Reuters
Tue, 03/27/18 - 11:29 am
AbbVie
Androgel
testosterone
Endo, GlaxoSmithKline close to settling testosterone liability cases
Fierce Pharma
Tue, 02/27/18 - 06:52 pm
Endo Pharmaceuticals
GSK
Auxilium
testosterone
The FDA still hates low T drugs — experts bat back a pair of contenders
Endpoints
Thu, 01/11/18 - 09:46 am
FDA
testosterone
Lipocine
Tlando
Clarus Therapeutics
Jatenzo
Endo unit cleared of liability in first testosterone replacement trial
Reuters
Sat, 11/18/17 - 09:38 am
Endo International
Auxilium
Testim
testosterone
AbbVie hit with $140M verdict in second bellwether AndroGel case
Fierce Pharma
Fri, 10/6/17 - 11:39 am
AbbVie
Androgel
heart attacks
testosterone
Repros to drop testosterone drug in U.S. if key study fails
Yahoo/Reuters
Thu, 04/14/16 - 04:43 pm
Repros
testosterone
FDA
clinical trials
Androxal
uterine fibroids
Proellex
Apricus shares are routed after testosterone drug fails to deliver clinical benefits
Fierce Biotech
Mon, 03/28/16 - 09:14 pm
Apricus Biosciences
testosterone
fispemifene
Repros tanks on another FDA hurdle for its 'low-T' treatment
Fierce Biotech
Fri, 10/30/15 - 09:51 am
Repros Therapeutics
testosterone
FDA
Androxal
AbbVie Challenges Fairness Of Upcoming Testosterone Trials
Forbes
Mon, 08/17/15 - 07:18 pm
AbbVie
testosterone
Androgel
Experts urge FDA to step in to quash 'Low-T' awareness efforts
Fierce Pharma Marketing
Mon, 06/15/15 - 04:39 pm
FDA
testosterone
off-label
What's Next For The Thousands Of Angry Men Suing Over Testosterone?
Forbes
Mon, 04/6/15 - 11:13 am
testosterone
AbbVie
Endo Health Solutions
Repros shares rally on testicle-stimulation drug application
Marketwatch
Thu, 04/2/15 - 09:58 am
Repros Therapeutics
testosterone
enclomiphene citrate
Androxal
FDA warning: men's testosterone drugs overused
Yahoo/AP
Wed, 03/4/15 - 08:25 am
FDA
warnings
testosterone
AbbVie
Eli Lilly
Axiron
Androgel
Niche Low-T lifestyle clinics might give suffering Lilly, AbbVie meds a boost
Fierce Pharma Marketing
Thu, 02/5/15 - 09:08 am
testosterone
Eli Lilly
AbbVie
Axiron
Androgel
Repros plummets as the FDA deals a blow to its low-T hopes
Fierce Biotech
Fri, 10/17/14 - 09:27 am
Repros Therapeutics
testosterone
FDA
Androxal

Pages